Review
Clinical Neurology
Spencer A. Nielson, Elliottnell Perez, Pablo Soto, Julia T. Boyle, Joseph M. Dzierzewski
Summary: This systematic review examines the cognitive mechanisms in cognitive behavioral therapy for insomnia (CBT-I), specifically focusing on maladaptive sleep beliefs. The findings suggest that reducing maladaptive sleep beliefs can improve insomnia severity, but does not impact sleep efficiency or other sleep parameters. It is also found that sometimes improvements in sleep parameters precede reductions in maladaptive beliefs. Therefore, targeting maladaptive sleep beliefs is an important aspect in improving insomnia.
SLEEP MEDICINE REVIEWS
(2023)
Article
Psychology, Multidisciplinary
Andrea Galbiati, Marco Sforza, Alessandro Scarpellino, Andrea Salibba, Caterina Leitner, Giada D'Este, Samantha Mombelli, Luigi Ferini-Strambi, Vincenza Castronovo
Summary: Metacognition, the ability to reflect on one's mental state and control thoughts and beliefs, is associated with various psychopathological conditions. For patients with insomnia, reactions to sleep-related thoughts and beliefs may contribute to hyperarousal. Cognitive behavioral therapy has beneficial effects on insomnia symptoms and dysfunctional beliefs in insomnia patients, but some individuals may still have metacognitive impairments.
FRONTIERS IN PSYCHOLOGY
(2021)
Article
Clinical Neurology
Hannah Scott, Janet M. Y. Cheung, Alexandria Muench, Hans Ivers, Michael A. Grandner, Charles M. Morin, Michael L. Perlis
Summary: Cognitive behavioural therapy for insomnia (CBT-I) improves total wake time but not total sleep time (TST) for most patients. However, in the 6-12 months following CBT-I, up to 64% of participants experience significant increases in TST. Baseline characteristics such as sleep continuity, mental health, and quality of life are associated with improvements in TST after CBT-I.
Article
Clinical Neurology
Ali Amidi, Cecilie R. Buskbjerg, Malene F. Damholdt, Jesper Dahlgaard, Frances P. Thorndike, Lee Ritterband, Robert Zachariae
Summary: This study investigated the long-term changes in sleep among breast cancer patients after receiving e-CBT-I treatment for 3 years. The results showed significant improvements in sleep quality and insomnia severity during the long-term follow-up assessment, but a substantial proportion of patients still experienced sleep disturbances.
Article
Clinical Neurology
Andrea Galbiati, Marco Sforza, Caterina Leitner, Anna Castelnovo, Giada D'Este, Luigi Ferini-Strambi, Mauro Manconi, Vincenza Castronovo
Summary: This study evaluated the response of insomnia patients to Cognitive-Behavioral Therapy for Insomnia (CBT-I) and found that the reliability and usefulness of objective total sleep time (oTST) in predicting CBT-I effectiveness is challenged. Future studies may focus on night-to-night variability experienced by insomnia patients for predicting CBT-I outcomes.
Article
Oncology
Diane Boinon, Cecile Charles, Leonor Fasse, Jonathan Journiac, Gloria Pallubicki, Kristopher Lamore, Gregory Ninot, Estelle Guerdoux-Ninot, Sebastien Gouy, Laurence Albiges, Suzette Delaloge, David Malka, David Planchard, Josee Savard, Sarah Dauchy
Summary: The study confirms the demand for VCBT-I among French cancer outpatients with insomnia, but also highlights limitations in terms of implementation and practicality. Remote professional support appears to be a core need to address these issues and personalize the guidance process.
SUPPORTIVE CARE IN CANCER
(2021)
Article
Medicine, General & Internal
Polina Pchelina, Simone B. Duss, Corrado Bernasconi, Thomas Berger, Tobias Krieger, Claudio L. A. Bassetti, Antoine Urech
Summary: Understanding the factors that predict the outcome of internet-based cognitive behavioral therapy for insomnia (iCBT-I) can help tailor the intervention to each patient. A secondary analysis of a trial comparing multicomponent iCBT-I and online sleep restriction therapy for 83 chronic insomnia patients was conducted. Prognostic and treatment-predictive factors were analyzed, revealing that duration of insomnia, gender, health-related quality of life, and total number of clicks were predictive of better outcomes. The study also found that treatment with benzodiazepines, sleep quality, and personal significance of sleep problems were prognostic for outcomes at follow-up assessment.
Review
Clinical Neurology
Dongmei He, Zhiwei Guo, Morgan A. Mcclure, Qiwen Mu, Binghu Jiang
Summary: Cognitive-behavioral therapy for insomnia (CBT-I) is recommended as the first-line treatment for insomnia. However, there are differences in therapeutic response between insomnia disorder with short sleep duration (ISS) phenotype and insomnia with normal sleep duration (INS) phenotype. A systematic review identified nine studies comparing the efficacy of CBT-I between ISS and INS phenotypes, and found that CBT-I had a better efficacy for INS phenotype with higher response and remission rates. The therapeutic response of ISS phenotype was significantly different from INS phenotype. Further research is needed to optimize the treatment for insomnia disorder with ISS phenotype.
SLEEP MEDICINE REVIEWS
(2023)
Article
Clinical Neurology
Onkar S. Marway, Parky H. Lau, Nicole E. Carmona, Colleen E. Carney
Summary: This study investigates the factors influencing insomnia severity perception and the reliability of the Insomnia Severity Index (ISI) after Cognitive Behavioral Insomnia Therapy (CBT-I). The findings suggest that post-CBT-I ISI scores are associated with pre-treatment ISI scores, as well as changes in fatigue and generalized anxiety symptoms. Clinicians should consider these factors when using the ISI as a treatment outcome measure.
Review
Clinical Neurology
Xingchen Shang, Linfei Ye, Man Ping Wang, Tai Hing Lam, Agnes Yuen Kwan Lai
Summary: The study found that pregnant women may benefit from cognitive behavioral therapy for insomnia in the short-term, but the long-term effectiveness remains unclear. More rigorous randomized controlled trials with long-term follow-ups are needed.
Article
Clinical Neurology
Yosuke Watanabe, Taiyo Kuroki, Daisuke Ichikawa, Motohiro Ozone, Naohisa Uchimura, Taro Ueno
Summary: This study examined the effects and safety of a smartphone-based cognitive behavioral therapy for insomnia (CBT-I) app compared to a sham app. The results showed that patients using the CBT-I app had greater improvement in insomnia symptoms compared to those using the sham app, with no adverse reactions or device failures detected.
Article
Clinical Neurology
Hannah Scott, Janet M. Y. Cheung, Alexandria Muench, Hans Ivers, Michael A. Grandner, Leon Lack, Charles M. Morin, Michael Perlis
Summary: The current form of cognitive behavioral therapy for insomnia does not significantly increase self-reported total sleep time (TST) in a large proportion of patients. Further investigation is needed to determine if increasing TST would benefit patients.
JOURNAL OF CLINICAL SLEEP MEDICINE
(2022)
Article
Clinical Neurology
Elaine M. Boland, Jennifer R. Goldschmied, Philip R. Gehrman
Summary: Rates of major depressive disorder (MDD) are increasing globally, and insomnia treatment may play a preventive role in reducing the risk of MDD onset. This systematic review evaluated the current evidence for the effects of cognitive behavioral treatment for insomnia (CBT-I) on preventing depression onset. Six studies were included, and the majority found lower rates of MDD onset in those who received CBT-I. However, methodological heterogeneity across the studies limits the ability to draw firm conclusions.
Article
Psychology, Clinical
Jennifer L. Martin, Gwendolyn C. Carlson, Monica R. Kelly, Yeonsu Song, Michael N. Mitchell, Karen R. Josephson, Sarah Kate McGowan, Najwa C. Culver, Morgan A. Kay, Alexander J. Erickson, Katie S. Saldana, Kimiko J. May, Lavinia Fiorentino, Cathy A. Alessi, Donna L. Washington, Elizabeth M. Yano
Summary: This study evaluated the effectiveness of acceptance and commitment therapy (ACT) for treating insomnia in women veterans through a randomized comparative trial. The results showed that both the ACT and cognitive behavioral therapy for insomnia (CBT-I) interventions were effective in improving sleep outcomes, although ABC-I was noninferior to CBT-I only for some sleep measures. ABC-I was superior to CBT-I in terms of treatment adherence. Overall, the findings suggest that ABC-I is a viable alternative to CBT-I for the treatment of insomnia in women veterans.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY
(2023)
Article
Clinical Neurology
Yun Li, Alexandros N. Vgontzas, Julio Fernandez-Mendoza, Jidong Fang, Kristina Puzino, Edward O. Bixler
Summary: This study compared the effects of trazodone and CBT-I on modifying spectral EEG activity during NREM sleep in patients with chronic insomnia. Trazodone was found to significantly decrease fast-frequency EEG activity during NREM sleep, indicating a stronger impact on cortical and physiological hyperarousal compared to CBT-I.
JOURNAL OF SLEEP RESEARCH
(2021)